24/7 Patient Assistance: 760-405-8205

Harvey Pass, MD

Thoracic & Cardiac Surgeon

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Pericardial Mesothelioma Pleural Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Harvey Pass is the current chief of the thoracic surgery division at the University of New York Langone Medical Center, specializing in the surgical treatment of mesothelioma. Dr. Pass graduated from Duke University Medical School in 1973, and completed several residencies at the University of Mississippi Medical Center, Duke University Medical School and Medical University of South Carolina. Dr. Harvey Pass completed a fellowship at the National Cancer Institute and with several decades worth of experience, he is well known as an advocate of asbestos awareness practices, and has used his knowledge to find better ways of treating this very severe type of cancer.


  • Education & Training

    dept_icon

    Johns Hopkins University

    Education

    dept_icon

    Duke University - 1973

    Medical School

    dept_icon

    Duke University Medical School; University of Mississippi Medical Center; Medical University of South Carolina

    Residency

    dept_icon

    National Cancer Institute

    Fellowship

  • Board Certifications

    American Board of Thoracic Surgery - Thoracic and Cardiac Surgery

  • Hospital & Practice

    NYU Langone Medical Center

    Languages: English/Spanish

    (212) 263-7319

    530 1st Avenue HCC-110

    New York, New York 10016

    Read More
  • Publications & Memberships

    Dr. Harvey Pass has contributed to 4 publications.

    Human Mesothelioma Samples Overexpress Both Cyclooxygenase-2 (COX-2) and Inducible Nitric Oxide Synthase (NOS2): In Vitro Antiproliferative Effects of a COX-2 Inhibitor

    Marrogi A1, Pass HI, Khan M, Metheny-Barlow LJ, Harris CC, Gerwin BI.

    See more >>

    Preoperative Tumor Volume Is Associated With Outcome In Malignant Pleural Mesothelioma

    Pass HI1, Temeck BK, Kranda K, Steinberg SM, Feuerstein IR.

    See more >>

    Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma

    Pass HI1, Temeck BK, Kranda K, Thomas G, Russo A, Smith P, Friauf W, Steinberg SM.

    See more >>

    Surgically debulked malignant pleural mesothelioma: results and prognostic factors

    Pass HI1, Kranda K, Temeck BK, Feuerstein I, Steinberg SM.

    See more >>

    Memberships

    American College of Surgeons

Verified Patient Reviews

Rate This Doctor

October 24, 2015

by Frank Mannino

Wait Time

Staff

Helpfulness

Knowledge

“Everything could not have been easier to meet and talk with Dr. Pass.”

March 28, 2015

by Leila B. Alexander

Wait Time

Staff

Helpfulness

Knowledge

“Dr. Pass is very professional. Virtually painless surgery, no pain recovery. Good doctor-patient relationship. Always polite and concerned not only of his patient but also of all other professional colleagues. ”

March 28, 2012

by Adelle T.

Wait Time

Staff

Helpfulness

Knowledge

“Dr. Pass is a good doctor he explains step by step what his patient needs to know about the illness. He is a very sympathetic doctor. ”

September 13, 2010

by Kathleen McEntee

Wait Time

Staff

Helpfulness

Knowledge

“Dr. Pass is an excellent doctor. I was assigned to him by my primary care physician. When I first visited him, he put my family and I at ease by describing us what needs to be done and how he would perform the operation. At the operation day he came into my room to talk with me and my family, explaining us the procedures. Because he is a very skilled surgeon, my operation went extremely well. After the surgery he followed up with me in the hospital, a very rare thing for an NYC doctor! It was nice to see that my doctor really cared about me. I can’t say enough good things about Dr. Pass as a doctor. His staff at NYU Hospital is awesome as well.”